Advanced Bionics, a subsidiary of Sonova Group, has received CE mark approval for its HiRes 90K Advantage cochlear implant with the HiFocus1J, HiFocus Helix and HiFocus Mid-Scala electrodes.
The approval has been granted for the implant to be used in patients with unilateral (asymmetric) hearing loss or otherwise called single-sided deafness (SSD).
Advanced Bionics president and Sonova medical division group vice-president Hansjuerg Emch said: "We are pleased that patients with single-sided deafness can now benefit from our cochlear implant technology."
The new AB electrode array HiFocus Mid-Scala electrode has been developed for optimal placement in the cochlea with low insertion force to protect its delicate structures and promotes the latest soft surgery approaches to suit surgeon preferences.
The company also provides speech understanding solutions, including ClearVoice speech enhancement technology and UltraZoom, in the Naída CI family of sound processors.
Established in 1993, Advanced Bionics develops cochlear implant technology and has sales in around 50 countries.
Image: HiRes 90K Advantage cochlear implant from Advanced Bionics. Photo: courtesy of Business Wire.